An initial safety trial of a potential coronavirus vaccine produced antibodies to the deadly disease in everyone who was tested, according to a report Tuesday. The neutralizing antibodies produced by Moderna Inc.’s vaccine were equivalent to the upper half of what’s seen in patients who get infected and recover, Bloomberg News said. Meanwhile, the side...
from New York Post https://ift.tt/2DIroAe
0 Comments